METHOD OF TREATING ESSENTIAL ARTERIAL HYPERTENSION IN ADOLESCENTS WITH OBSTRUCTIVE SLEEP APNOEA/HYPNOEA SYNDROME Russian patent published in 2013 - IPC A61M16/06 A61N5/06 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely paediatrics, cardiology, somnology, and may be used for treating adolescents with essential arterial hypertension with obstructive sleep apnoea/hypnoea syndrome. For this purpose, nasal non-invasive lung ventilation by nocturnal nasal continuous positive airway pressure (nCPAP-therapy) and light therapy with a therapeutic health-improving lamp with underlying standard therapeutic regimens. The nCPAP-therapy involves 10 monthly procedures for three months with a session length of 8 hours. The light therapy are performed once a day during a first hour after wakening up, a length of procedure is 30 minutes; the therapeutic course is 10 days for a first month of therapy.

EFFECT: method provides normalising the blood pressure level ensured by correcting obstructive respiratory sleeping disorders and normalising the circadian rhythm system.

1 ex